Rpts. GENERAL General Schedule (Code GE) Program Prescriber type: Dental Medical Practitioners Nurse practitioners Optometrists Midwives

Transcription

1 Esomeprazole 20mg Name, Restriction, Manner of esomeprazole 20 mg enteric tablet, 30 (8886Q) (029W) Gastric ulcer Peptic ulcer Treatment Phase: Initial treatment The therapy must be for initial treatment of a peptic ulcer, in a patient testing negative for helicobacter pylori infection OR The patient must have failed treatment with helicobacter pylori eradication therapy

2 Helicobacter pylori eradication therapy should be considered. Low-dose proton pump inhibitors are appropriate step-down therapy A low- dose proton pump inhibitor includes: lansoprazole mg, omeprazole 0mg, pantoprazole 20mg and rabeprazole 0mg No increase in the maximum quantity or number of units may be No increase in the maximum number of repeats may be authorised

3 Name, Restriction, Manner of esomeprazole 20 mg enteric tablet, 30 (8600P) (0343J) Scleroderma oesophagus Low dose proton pump inhibitors are appropriate step-down therapy A low dose proton pump inhibitor includes: lansoprazole mg, omeprazole 0mg, pantoprazole 20mg and rabeprazole 0mg No increase in the maximum quantity or number of units may be authorised

4 Name, Restriction, Manner of esomeprazole 20 mg enteric tablet, 30 (8600P) (0343J) Pathological hypersecretory conditions including Zollinger-Ellison syndrome and idiopathic hypersecretion Low dose proton pump inhibitors are appropriate step-down therapy A low dose proton pump inhibitor includes: lansoprazole mg, omeprazole 0mg, pantoprazole 20mg and rabeprazole 0mg No increase in the maximum quantity or number of units may be authorised

5 Name, Restriction, Manner of esomeprazole 20 mg enteric tablet, 30 (8600P) (0343J) Gastro-oesophageal reflux disease The treatment must be for maintenance therapy AND The condition must be healed The treatment must be maintenance therapy for erosive reflux oesophagitis AND The condition must have been previously diagnosed by endoscopy Low dose proton pump inhibitors are appropriate step-down therapy A low dose proton pump inhibitor includes: lansoprazole mg, omeprazole 0mg, pantoprazole 20mg and rabeprazole 0mg No increase in the maximum quantity or number of repeats

6 Name, Restriction, Manner of esomeprazole 20 mg enteric tablet, 30 (New) (New) Gastro-oesophageal reflux disease The treatment must be for initial treatment of symptomatic gastrooesophageal reflux disease OR The treatment must be for the short-term maintenance of gastrooesophageal reflux disease Low dose proton pump inhibitors are appropriate step-down therapy A low dose proton pump inhibitor includes: lansoprazole mg, omeprazole 0mg, pantoprazole 20mg and rabeprazole 0mg

7 Esomeprazole 40mg Name, Restriction, Manner of esomeprazole 40 mg enteric tablet, 30 (340B) esomeprazole 40 mg capsule, 30 (033R) Pathological hypersecretory conditions including Zollinger-Ellison syndrome and idiopathic hypersecretion Patients symptoms must be inadequately controlled using a standard dose proton pump inhibitor. Pharmaceutical benefits that have the form esomeprazole tablet 40 capsule 40 mg are equivalent for the purposes of substitution. Continuing Therapy Only: For prescribing by nurse practitioners as continuing therapy only, where the treatment of, and prescribing of medicine for, a patient has been initiated by a medical practitioner. Further information can be found in the Explanatory s for Nurse Practitioners. A standard dose proton pump inhibitor includes: esomeprazole 20mg, lansoprazole 30mg, omeprazole 20mg, pantoprazole 40mg, rabeprazole 20mg

8 Name, Restriction, Manner of esomeprazole 40 mg enteric tablet, 30 (340B) esomeprazole 40 mg capsule, 30 (033R) Scleroderma oesophagus Patients symptoms must be inadequately controlled using a standard dose proton pump inhibitor. Pharmaceutical benefits that have the form esomeprazole tablet 40 capsule 40 mg are equivalent for the purposes of substitution. Continuing Therapy Only: For prescribing by nurse practitioners as continuing therapy only, where the treatment of, and prescribing of medicine for, a patient has been initiated by a medical practitioner. Further information can be found in the Explanatory s for Nurse Practitioners. A standard dose proton pump inhibitor includes: esomeprazole 20mg, lansoprazole 30mg, omeprazole 20mg, pantoprazole 40mg, rabeprazole 20mg

9 Name, Restriction, Manner of esomeprazole 40 mg enteric tablet, 30 (860Q) esomeprazole 40 mg capsule, 30 (0330Q) Gastro-oesophageal reflux disease Treatment Phase: Initial treatment The treatment must be for the healing of gastro-oesophageal reflux disease The treatment must be for the initial treatment of erosive reflux oesophagitis AND The condition must be proven by endoscopy Pharmaceutical benefits that have the form esomeprazole tablet 40 mg and pharmaceutical benefits that have the form esomeprazole capsule 40 mg are equivalent for the purposes of substitution. No increase in the maximum quantity or number of units may be authorised No increase in the maximum number of repeats may be authorised authorised